Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $3.6 million.

  • Angiodynamics' Restructuring Costs fell 3805.39% to $3.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $11.8 million, marking a year-over-year decrease of 7806.93%. This contributed to the annual value of $15.6 million for FY2025, which is 7062.92% down from last year.
  • Angiodynamics' Restructuring Costs amounted to $3.6 million in Q4 2025, which was down 3805.39% from $2.8 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Restructuring Costs registered a high of $35.4 million during Q1 2024, and its lowest value of $610000.0 during Q1 2021.
  • In the last 5 years, Angiodynamics' Restructuring Costs had a median value of $3.3 million in 2023 and averaged $5.9 million.
  • As far as peak fluctuations go, Angiodynamics' Restructuring Costs soared by 102401.83% in 2021, and later plummeted by 9070.89% in 2025.
  • Quarter analysis of 5 years shows Angiodynamics' Restructuring Costs stood at $2.3 million in 2021, then skyrocketed by 35.77% to $3.1 million in 2022, then soared by 102.29% to $6.2 million in 2023, then fell by 5.17% to $5.9 million in 2024, then tumbled by 38.05% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q4 2025, $2.8 million for Q3 2025, and $2.2 million during Q2 2025.